Orise
Payments companies reported to CMS as associated with Orise. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Orise, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Orise
These are the largest totals companies reported as associated with Orise. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Joo Hwang | Stanford, CA | Gastroenterology (Internal Medicine) | $60,184.36 |
| Hiroyuki Aihara | Boston, MA | Gastroenterology (Internal Medicine) | $56,357.84 |
| Norio Fukami | Scottsdale, AZ | Gastroenterology (Internal Medicine) | $39,111.26 |
| Peter Draganov | Gainesville, FL | Gastroenterology (Internal Medicine) | $25,123.32 |
| Mohamed Othman | Houston, TX | Gastroenterology (Internal Medicine) | $23,304.78 |
| Amrita Sethi | New York, NY | Gastroenterology (Internal Medicine) | $16,361.11 |
| Alexander Schlachterman | Philadelphia, PA | Gastroenterology (Internal Medicine) | $14,285.78 |
| Phillip Ge | Houston, TX | Gastroenterology (Internal Medicine) | $11,825.41 |
| Danny Issa | West Hills, CA | Gastroenterology (Internal Medicine) | $9,373.55 |
| Moamen Gabr | Cincinnati, OH | Gastroenterology (Internal Medicine) | $9,264.68 |
Prescribed Orise?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.